INFLIXIMAB

infliximab 120 mg/mL injection, 1 mL syringe

INFLIXIMAB (12555T)

infliximab 120 mg/mL injection, 1 mL syringe
12555T
Body System:
Manner of administration:Injection
General Schedule
Authority Required

Restriction

Indication: Severe active rheumatoid arthritis
Treatment phase: Balance of supply for Initial treatment - subcutaneous form
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 0 DPMQ: $384.51 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Remsima SC